ANRS CO5 VIH2
ANRS CO5 Cohort “National Cohort HIV-2”
Topic
HIV-2 Infection
Sponsor
Inserm-ANRS
Coordinating investigator
Jade GHOSN MD, PhD – AP-HP / Sophie MATHERON MD, PhD – AP-HP
Short description
The HIV2 cohort describe natural history of HIV-2 infection in adult patients living and followed in France
Study design
French prospective, multicentric, observational cohort
Primary objective
To study HIV-2 infection in adult patients followed in France
Primary endpoint
Study HIV-2 infection rate in adult patients followed in France
Study population
HIV-2 infected participant followed in one of the participating centers in France
Intervention
Study the response to antiretroviral treatment (clinical, immuno-virological) and contribute to the identification of the antiretroviral strategies and combinations most suited to the particularities of the infection.
Number of subjects
1217 participants
Participating country(ies) and sites
France (116 centres)
Study duration
28 years
Funding
Inserm – ANRS | MIE
UMS MART activities
Coordination, Methodology, Monitoring, Data Management and Statistical Analysis